REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAE Systems Regulatory News (BA.)

Share Price Information for BAE Systems (BA.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,392.00
Bid: 1,390.50
Ask: 1,391.50
Change: 10.50 (0.76%)
Spread: 1.00 (0.072%)
Open: 1,377.00
High: 1,398.00
Low: 1,376.50
Prev. Close: 1,381.50
BA. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

25 Jun 2020 07:00

RNS Number : 0055R
BAE SYSTEMS PLC
25 June 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 - FOR IMMEDIATE RELEASE 25 June 2020

BAE Systems plc - pre close market update

BAE Systems plc provides the following update in light of the ongoing COVID-19 pandemic and ahead of entering its close period before the Half Year results announcement on 30th July.

 

Current business priorities

Given the critical nature of the products and services that we provide to a number of nations, the important role we play in national economies and the local communities in which we operate, the Group has continued to focus on its near-term priorities:

1) Protecting the wellbeing of our employees

2) Meeting customer priorities as they face unique challenges

3) Supporting our supply chain in dealing with pandemic related disruption

4) Preserving and protecting our capabilities and the strength of the Group's business which is underpinned by our c.£45bn order backlog and programme positions

5) Ensuring that we maintain appropriate liquidity and balance sheet strength

 

In parallel, we have taken actions to enhance the Company's resilience and position the business towards a return to full operational tempo. In many of our defence operations, the number of employees now working has progressed to near normal levels, whether through working on site in accordance with adjusted protective safety measures or through working remotely from home.

Based on current expectations, further improvements are expected to be progressively achieved during the third quarter.

 

We continue to drive the key actions as outlined in February:

· Completing the two US acquisitions, one of which completed in May

· Injecting a one-off £1bn payment into the UK pension scheme, which took place in April

· Investing in new facilities to meet the growth profile in a number of sectors

 

Supporting governments and communities in our key markets

We continue to support governments and communities in the countries where we operate as they respond to the COVID-19 pandemic. We have deployed our 3D printing capabilities and collaborated with our supply chain to donate more than 150,000 items of Personal Protective Equipment (PPE) to healthcare workers in the US and the UK. We are proud to support ventilator production as part of the VentilatorChallenge UK consortium. We are also supporting our communities in the US, UK, Australia and Saudi Arabia through the provision of online educational resources for young people as well as financial support to healthcare providers and local charities to enable them to provide care packages and food relief to the most vulnerable. Much of our outreach work has been supported by our employees who have volunteered their time and skills to help local relief efforts. We are also delighted to be proceeding with our plans to recruit a record number of apprentices, some 800 in total across a wide number of our sites.

 

Trading update

As expected, the pandemic has impacted the business in the second quarter, with sites in the Air and Maritime sectors and our US commercial avionics business being most affected. However, as a result of the actions taken, productivity levels in June have improved within our defence businesses (which account for around 90% of the Group's revenues). Many of these operations now have well over 90% of employees working. This includes a high proportion working from home and critical on-site workers having returned under adjusted protective safety measures in response to the pandemic. In parallel the business continues to drive cost control measures.

Within our UK-based Air and Maritime sectors, second quarter disruptions have particularly impacted cost recoveries and sales volumes, offset to some degree by strong underlying operational performance and cost control measures. Product delivery levels in MBDA have also been impacted given the European locations of its factories.

 

Our US-based Controls and Avionics business has been and is expected to be impacted for the near-term, especially in the commercial aftermarket and product delivery lines. The Power and Propulsion business has been impacted by the reduced demand for mass transit in recent months, and commercial cyber operations have also seen reduced trading levels.

 

In the US, our defence manufacturing facilities and shipyards have continued to operate following implementation of appropriate safe working measures. There has been some disruption to manufacturing operations primarily due to the pandemic's impact on the supply chain, as well as some intermittent production delays in our own lines where precautionary measures to reduce COVID-19 exposure were necessary.

Programme status update - key highlights

In the second quarter, despite having to rapidly adjust to new working practices the defence business has continued to deliver strong operational performance in support of our customers' critical activities. A number of highlights include:

· Astute Boat 4 and the fourth Offshore Patrol Vessel were accepted by the Royal Navy, and HMS Queen Elizabeth was able to commence the next phase of Royal Navy sea trials.

· Key milestones on the Qatar Typhoon programme were achieved.

· The Combat Mission Systems Business continued to make progress towards achieving consistent quality and production across multiple combat vehicle programmes by investing in modernising facilities and implementing improved manufacturing technologies.

· APKWS® successfully demonstrated a ground-launch capability.

 

Outlook

Demand for our capabilities remains high with order intake in line with our original expectations for the year.

 

Sales for the half year are expected to be broadly stable year on year whilst half year profit is expected be c.15% lower than last year primarily due to cost under recoveries in the period, significantly reduced volumes in higher margin commercial work and the sales mix year on year. As we return towards full operational tempo we expect the business performance in the second half to be much stronger than in the first half, assuming no new significant COVID-19 related disruptions.

The liquidity of the Group remains strong. As in prior years, cash has a significant first half working capital outflow. Despite some additional profit to cash impacts from COVID-19 disruptions, operating business cashflow in the half-year remains broadly in line with expectations and, excluding the one-off £1bn injection into the UK pension scheme, is likely to be consistent with the first half cash profiles seen in the last two years.

 

Acquisitions

The $275m acquisition of the Airborne Tactical Radios business completed in May and its integration into the Electronic Systems C4ISR Systems business is underway. The proposed acquisition of the Collins Aerospace Military Global Positioning System business continues to fulfil the closing conditions and remains on track to close early in the second half.

 

Pension

In line with the new funding contributions outlined in February 2020, both the £240m contribution in respect of the scheme year ended 31 March 2020 and the one-off £1bn raised through the bond issuance in April have been made.

 

Final dividend payment

Following the announcement in April to defer the decision on the 2019 final dividend payment, the Board will provide an update with the Group's Half Year results next month. 

For further information please contact:

Investors

Media Relations

Martin Cooper,

Investor Relations Director

Telephone: +44 (0)1252 383455

Email: investors@baesystems.com

Kristina Anderson,

Director, Media Relations

Telephone: +44 (0) 7540 628673

Email: Kristina.anderson@baesystems.com

 

 

Issued by:

Martin Cooper - Investor Relations DirectorBAE Systems plc

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKQBNKBKBCAB
Date   Source Headline
9th May 20246:17 pmRNSTransaction in Own Shares
9th May 20244:52 pmRNSCompany Secretary Change
9th May 202410:49 amRNSResult of AGM
9th May 20247:00 amRNSAGM Trading Statement
8th May 20246:03 pmRNSTransaction in Own Shares
7th May 20246:17 pmRNSTransaction in Own Shares
3rd May 20245:56 pmRNSTransaction in Own Shares
2nd May 20245:41 pmRNSTransaction in Own Shares
1st May 20246:08 pmRNSTransaction in Own Shares
30th Apr 20246:12 pmRNSTransaction in Own Shares
30th Apr 202410:12 amRNSTotal Voting Rights
29th Apr 20245:18 pmRNSTransaction in Own Shares
26th Apr 20245:49 pmRNSTransaction in Own Shares
25th Apr 20246:17 pmRNSTransaction in Own Shares
24th Apr 20246:06 pmRNSTransaction in Own Shares
23rd Apr 20245:43 pmRNSTransaction in Own Shares
22nd Apr 20245:25 pmRNSTransaction in Own Shares
19th Apr 20245:23 pmRNSTransaction in Own Shares
18th Apr 20246:22 pmRNSTransaction in Own Shares
18th Apr 20244:48 pmRNSDirector/PDMR Shareholding
17th Apr 20245:38 pmRNSTransaction in Own Shares
17th Apr 20241:39 pmRNSDirector/PDMR Shareholding
16th Apr 20246:01 pmRNSTransaction in Own Shares
15th Apr 20245:26 pmRNSTransaction in Own Shares
12th Apr 20245:16 pmRNSTransaction in Own Shares
11th Apr 20246:30 pmRNSTransaction in Own Shares
11th Apr 202411:15 amRNSDoc re: AGM documents
10th Apr 20246:05 pmRNSTransaction in Own Shares
9th Apr 20246:23 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
5th Apr 20241:04 pmRNSDirector/PDMR Shareholding
4th Apr 20245:23 pmRNSTransaction in Own Shares
3rd Apr 20245:09 pmRNSTransaction in Own Shares
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:41 pmRNSTransaction in Own Shares
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:38 pmRNSDirector/PDMR Shareholding
28th Mar 202411:25 amRNSDirector Declaration
28th Mar 202410:50 amRNSTotal Voting Rights
27th Mar 20245:25 pmRNSTransaction in Own Shares
26th Mar 20245:04 pmRNSTransaction in Own Shares
25th Mar 20245:14 pmRNSTransaction in Own Shares
22nd Mar 20245:33 pmRNSTransaction in Own Shares
21st Mar 20246:22 pmRNSTransaction in Own Shares
21st Mar 20242:03 pmRNSDirector/PDMR Shareholding
20th Mar 20245:52 pmRNSTransaction in Own Shares
20th Mar 202412:22 pmRNSDirector/PDMR Shareholding
20th Mar 20249:15 amRNSNotes Issuance
19th Mar 20245:43 pmRNSTransaction in Own Shares
18th Mar 20245:46 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.